文献速递复苏、休克与脓毒症心脑血管急症重症综合管理与镇静镇痛

比较血管加压素与去甲肾上腺素在难治性心源性休克合并心脏骤停并经VA-ECMO复苏的猪模型中的效果

Comparison of Vasopressin versus Norepinephrine in a Pig Model of Refractory Cardiogenic Shock Complicated by Cardiac Arrest and Resuscitated with Veno-arterial ECMO.
PubMed 文献 · Shock · 2021-01-01
一句话结论在VA-ECMO复苏的难治性心脏骤停猪模型中,血管加压素较去甲肾上腺素乳酸清除更快、液体复苏量更少、肺水肿更轻,而全身及区域血流动力学效应相似。

该研究在20头猪中诱导心脏骤停,经30分钟CPR后启动VA-ECMO,随机分为精氨酸血管加压素(AVP)组或去甲肾上腺素(NE)组,药物滴定维持MAP 65 mmHg,比较ECMO启动后6小时内的效果。结果显示两组ECMO流量和MAP无差异,但NE组液体复苏量更高(14,000 [11,250-15,250] mL vs. 3,500 [1,750-4,000] mL,P<0.05),NE组肺湿/干重比更高,AVP组H0-H6乳酸清除率更高(47.84 [13.42-82.73]% vs. 25.66 [-7.31-35.34]%,P<0.05),舌下微循环无显著差异,AVP组H3和H6组织氧饱和度更高(P<0.05),两组肝肾功能 evolution 相似。结论提示在VA-ECMO复苏的难治性心脏骤停中,AVP较NE可能减少液体需求并改善乳酸清除,但需临床验证。

要点

  • 在VA-ECMO复苏的难治性心脏骤停猪模型中,AVP组6小时液体复苏量显著低于NE组(3,500 [1,750-4,000] mL vs. 14,000 [11,250-15,250] mL,P<0.05)。
  • AVP组H0-H6乳酸清除率显著高于NE组(47.84 [13.42-82.73]% vs. 25.66 [-7.31-35.34]%,P<0.05)。
  • NE组肺湿/干重比高于AVP组,提示NE组肺水肿更重。
  • 两组ECMO流量和MAP无差异,舌下微循环值无显著差异;AVP组H3和H6组织氧饱和度更高(P<0.05)。
  • 两组肝肾功能 evolution 相似;研究为动物模型,不能直接外推至临床决策。

适用人群与场景

  • 猪模型:冠状动脉结扎诱导心脏骤停,经30分钟CPR后启动VA-ECMO,模拟难治性心源性休克合并心脏骤停并ECMO复苏的场景。
  • 原文未提及人类适用人群、排除标准或具体ICU/急诊场景。

诊断标准与关键阈值

  • 原文未提及诊断标准或关键阈值(除MAP目标65 mmHg外)。

处置流程与药物剂量

  • 第一步:心脏骤停后经30分钟CPR,启动VA-ECMO。
  • 第二步:随机分组,分别给予精氨酸血管加压素(AVP)或去甲肾上腺素(NE),药物滴定维持MAP 65 mmHg,观察ECMO启动后6小时。
  • 原文未提及具体药物剂量、单位、给药途径、频次或疗程。

红旗征与不能漏的情况

  • 原文未提及

研究设计与关键结果

  • 研究类型:随机对照动物实验;样本量:20头猪;单中心(原文未明确中心数,但为动物模型)。
  • 干预与对照:AVP组 vs. NE组,药物滴定维持MAP 65 mmHg。
  • 主要终点结果:两组ECMO流量和MAP无差异;NE组液体复苏量更高(14,000 [11,250-15,250] mL vs. 3,500 [1,750-4,000] mL,P<0.05);NE组肺湿/干重比更高;AVP组H0-H6乳酸清除率更高(47.84 [13.42-82.73]% vs. 25.66 [-7.31-35.34]%,P<0.05)。
  • 关键次要终点:舌下微循环值无显著差异;AVP组H3和H6组织氧饱和度更高(P<0.05);两组肝肾功能 evolution 相似。
  • 不良事件:原文未提及。

证据类型、等级与局限

  • 证据类型:随机对照动物实验(猪模型)。
  • 证据等级或推荐强度:原文未提及。
  • 局限:动物模型,样本量小(20头猪),结果不能直接外推至人类;原文未提及盲法、分配隐藏等细节。

对床旁实践的改变

  • 在VA-ECMO复苏的难治性心脏骤停动物模型中,AVP较NE减少液体复苏需求并改善乳酸清除,但该结果尚未在人类中验证,不能直接改变临床实践。
  • 适用与不适用人群:仅适用于该猪模型场景,原文未提供人类适用或不适用人群。
  • 常见陷阱:不能将动物模型中的液体复苏量或乳酸清除率差异直接作为人类决策阈值;原文未提及药物剂量,不能推断临床用药方案。

指南或共识出处

  • 原文未提及

以上提炼依据论文摘要(全文未开放获取,或许可不允许翻译转载);全文请点「阅读原文」。

英文原文(摘要)· 点击展开

BACKGROUND: The choice of the best vasopressor after ExtraCorporeal Membrane Oxygenation (ECMO) implantation after cardiac arrest is not well defined. Circulatory flow recovery with ECMO is associated with vasoplegia and vasopressor need. The present study aimed to compare the effects of norepinephrine and vasopressin in the first 6 h after ECMO initiation.

METHODS: Cardiac arrest was induced in 20 pigs by coronary surgical ligature and veno-arterial-ECMO was started after a 30-min period of cardio-pulmonary resuscitation. Pigs were randomized into two groups, arginine vasopressin (AVP) or norepinephrine (NE), with the drugs titrated to maintain a mean arterial pressure (MAP) at 65 mm Hg. Macrocirculatory and metabolic parameters were assessed by lactate clearance. Microcirculatory parameters were assessed by sublingual microcirculation with Sidestream Dark Field imaging and peripheral Near InfraRed Spectroscopy. Pulmonary edema was evaluated by measuring lung wet/dry weight ratio.

RESULTS: No difference was found between groups regarding ECMO flow and MAP. Fluid resuscitation volume was higher in the NE group (14,000 [11,250-15,250] mL vs. 3,500 [1,750-4,000] mL in the AVP group, P < 0.05). Lung wet/dry weight ratio was higher in the Norepinephrine group. Lactate clearance between H0 and H6 was higher in the AVP group (47.84 [13.42-82.73]% vs. the NE group 25.66 [-7.31 to 35.34)% vs. P < 0.05). No significant difference was observed for sublingual microcirculation values. Baseline tissue oxygen saturation was comparable and higher at both H3 and H6 in the Vasopressin group comparatively to the Norepinephrine group (P < 0.05). Renal and liver function evolution also remained similar in the two groups throughout the study.

CONCLUSIONS: AVP administration in refractory cardiac arrest resuscitated by veno-arterial-ECMO is associated with a faster lactate clearance, less fluid resuscitation, and less pulmonary edema when compared with NE for similar global and regional hemodynamic effects.

来源:Shock,查看原文。版权归原作者所有。

参考来源

  1. Klein T, Grandmougin D, Liu Y, et al. Comparison of Vasopressin versus Norepinephrine in a Pig Model of Refractory Cardiogenic Shock Complicated by Cardiac Arrest and Resuscitated with Veno-arterial ECMO. Shock. 2021. PMID: 33555846. doi:10.1097/SHK.0000000000001747

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。